Aayush Food and Herbs Ltd

Aayush Wellness Ltd has announced the cut-off date for e-voting for its 42nd Annual General Meeting (AGM) will be Tuesday, September 22, 2026. The AGM is scheduled for Tuesday, September 29, 2026, at 2:00 PM IST, to be conducted via Video Conferencing (VC) and Other Audio Visual Means (OAVM). The remote e-voting period will commence on Saturday, September 26, 2026, at 9:00 AM IST and conclude on Monday, September 28, 2026, at 5:00 PM IST. Central Depository Services (India) Limited (CDSL) has been appointed to facilitate the remote e-voting and e-voting during the AGM.

Aayush Wellness Ltd announced the resignation of Mr. Naveenakumar Kunjaru from his position as Managing Director, effective September 09, 2026. The resignation is attributed to personal and family commitments. Mr. Kunjaru also holds directorships in Empower India Limited, where he chairs the Audit, Nomination and Remuneration, and Stakeholders Relationship Committees. He has confirmed no other material reasons for his resignation.

Aayush Wellness Ltd has submitted its 42nd Annual Report for the Financial Year 2025-26, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report details the company's corporate overview, including its vision of building an integrated preventive healthcare ecosystem across herbal alternatives, nutraceuticals, and diagnostics. It also contains the notice for the 42nd Annual General Meeting, statutory reports, standalone and consolidated financial statements, and other relevant corporate information. The Annual Report is available on the company's website.

Aayush Wellness Ltd has submitted its 42nd Annual Report for the Financial Year 2025-26, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report details the company's corporate overview, including its vision of building an integrated preventive healthcare ecosystem across herbal alternatives, nutraceuticals, and diagnostics. It also contains the notice for the 42nd Annual General Meeting, statutory reports, standalone and consolidated financial statements, and other relevant corporate information. The Annual Report is available on the company's website.

Aayush Wellness Limited has announced its 42nd Annual General Meeting (AGM) for the Financial Year 2025-26. The meeting is scheduled to be held on Tuesday, September 29, 2026, at 02:00 P.M. via Video Conferencing (VC) and Other Audio-Visual Means (OAVM). Key agenda items include the approval of audited standalone and consolidated financial statements for the year ended March 31, 2026, the reappointment of Mr. Gavadu Patil as a Director, and the appointment of M/s. A. Raghavendra Rao & Associates as Statutory Auditors for a term of five years.

Aayush Wellness Limited's Board of Directors met on September 3, 2026, approving key items for the upcoming 42nd Annual General Meeting (AGM). The board approved the notice of the AGM, along with the Board's Report for the financial year ended March 31, 2026. The 42nd AGM is scheduled for September 29, 2026, via Video Conferencing. The cut-off date for member eligibility to vote is September 22, 2026, with remote e-voting from September 26 to September 28, 2026. Additionally, the board approved the re-appointment of Mr. Gavadu Patil as a Non-Executive Non-Independent Director and the appointment of M/s. A. Raghavendra Rao & Associates as Statutory Auditors for a five-year term.

Aayush Wellness Ltd has responded to a BSE query regarding recent significant price movements in its stock. The company stated that it has consistently disclosed all material events and price-sensitive information as required by SEBI regulations. Aayush Wellness clarified that it is not aware of any impending announcements or information that could be influencing the stock's price behavior. The company assured continued compliance with disclosure norms.

Aayush Wellness Limited has launched "Lung Care Tablets" to tap into India's ₹18,913 crore respiratory healthcare market. This move expands the company's focus on preventive wellness and nutraceutical solutions, addressing health concerns related to smoking, air pollution, and environmental exposure. The Indian respiratory healthcare segment saw a 10% year-on-year growth in sales, reaching ₹18,912.64 crore in 2025. Aayush Wellness aims to build a differentiated position in the preventive respiratory-wellness category with its science-backed formulation containing N-Acetyl Cysteine, Vasaka Extract, and other immune-supportive ingredients.

Aayush Wellness Limited announced its un-audited consolidated financial results for Q1 FY27, reporting a 46.3% year-on-year growth in revenue from operations to ₹33.11 crore. Profit After Tax (PAT) increased by 22.6% YoY to ₹1.42 crore, and Earnings Per Share (EPS) rose to ₹0.29. The company attributed the growth to an expanded product portfolio, scaled-up digital commerce channels, and improved distribution efficiency. Management highlighted continued progress in building a scalable consumer healthcare platform and a focus on product innovation, market penetration, and international expansion.

Aayush Wellness Limited announced its un-audited consolidated financial results for the quarter ended June 30, 2026 (Q1 FY27). The company reported a significant 46.3% year-on-year (YoY) growth in revenue from operations, reaching ₹33.11 crore compared to ₹22.63 crore in Q1 FY26. Profit After Tax (PAT) saw a 22.6% YoY increase to ₹1.42 crore from ₹1.16 crore, and a substantial 150.8% quarter-on-quarter (QoQ) jump from ₹0.56 crore in Q4 FY26. Earnings Per Share (EPS) rose to ₹0.29 from ₹0.24 YoY. Growth drivers include product portfolio expansion, digital commerce scale-up, and improved distribution efficiency. The company is focusing on product innovation, penetrating Tier 2/3 markets, and exploring international expansion.